Výsledky vyhľadávania - "Selective Estrogen Receptor Modulators/therapeutic use"

Targeting Oestrogen Receptor Signalling in Breast Cancer Therapy

Autori: Howell, Sacha J Howell, Anthony

Zdroj: Advances in Experimental Medicine and Biology ISBN: 9783031708749
Howell, S J & Howell, A 2025, Targeting Oestrogen Receptor Signalling in Breast Cancer Therapy. in A Guide to Breast Cancer Research : From Cellular Heterogeneity and Molecular Mechanisms to Therapy. Advances in Experimental Medicine and Biology, vol. 1464, Springer Nature, pp. 449-474. https://doi.org/10.1007/978-3-031-70875-6_22

Predmety: Selective Estrogen Receptor Modulators, Antineoplastic Agents, Hormonal/therapeutic use, Antineoplastic Agents, Hormonal, Aromatase Inhibitors, Antineoplastic Agents, Breast Neoplasms, Breast Neoplasms/drug therapy, Estrogen Receptor Antagonists/therapeutic use, Receptors, Estrogen, Signal Transduction/drug effects, Selective Estrogen Receptor Modulators/therapeutic use, Receptors, Humans, Animals, Female, Estrogen/metabolism, Receptors, Estrogen/metabolism, Hormonal/therapeutic use, Molecular Targeted Therapy/methods, Aromatase Inhibitors/therapeutic use, Signal Transduction

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39821038
https://research.manchester.ac.uk/en/publications/79ac5dd8-2fdd-4734-bc60-6c0a12c34d02
https://doi.org/10.1007/978-3-031-70875-6_22

Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product–Drug Interaction

Autori: Gufford, Brandon T Chen, Gang Vergara, Ana G a ďalší

Zdroj: Drug Metabolism and Disposition. 43:1353-1359

Predmety: Selective Estrogen Receptor Modulators, Selective Estrogen Receptor Modulators - therapeutic use, Glucuronides - metabolism, Raloxifene Hydrochloride - therapeutic use, Selective Estrogen Receptor Modulators - metabolism, Breast Neoplasms, 3. Good health, Silybum marianum, 03 medical and health sciences, Breast Neoplasms - prevention & control, Glucuronides, 0302 clinical medicine, Milk Thistle - chemistry, Raloxifene Hydrochloride, Raloxifene Hydrochloride - metabolism, Intestines - metabolism, Humans, Drug Interactions, Female, Intestinal Mucosa

Prístupová URL adresa: https://europepmc.org/articles/pmc4538855?pdf=render
https://pubmed.ncbi.nlm.nih.gov/26070840
https://dmd.aspetjournals.org/content/43/9/1353
https://europepmc.org/article/MED/26070840
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538855/
http://dmd.aspetjournals.org/content/early/2015/07/14/dmd.115.065086
https://pubmed.ncbi.nlm.nih.gov/26070840/
https://dmd.aspetjournals.org/content/dmd/early/2015/06/12/dmd.115.065086.full.pdf

Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer

Autori: Seung Il Kim Byeong Woo Park Joo Hang Kim a ďalší

Prispievatelia: Seung Il Kim Byeong Woo Park Joo Hang Kim a ďalší

Zdroj: The Breast. 22:1205-1209

Predmety: Breast Neoplasms/pathology, Kaplan-Meier Estimate, PR, progesterone receptor, PFS, Palliative Care, Breast cancer, 0302 clinical medicine, MHT, Receptors, Progesterone/analysis, Neoplasm Metastasis, progression free survival, Antineoplastic Agents/therapeutic use, Aromatase Inhibitors, Aromatase Inhibitors/therapeutic use, Selective Estrogen Receptor Modulators/adverse effects, Selective Estrogen Receptor Modulators/therapeutic use, OS, Middle Aged, 3. Good health, Receptors, Estrogen, Estrogen/analysis, Breast Neoplasms/drug therapy, Female, metastatic breast cancer, Receptors, Progesterone, estrogen receptor, Adult, Selective Estrogen Receptor Modulators, MBC, Maintenance, overall survival, Antineoplastic Agents, Breast Neoplasms, Disease-Free Survival, Maintenance Chemotherapy, medroxyprogesteron acetate, 03 medical and health sciences, Humans, Hormone therapy, Aged, Retrospective Studies, maintenance hormone therapy, response evaluation criteria in solid tumors, Antineoplastic Agents/adverse effects, Breast Neoplasms/chemistry, MPA, ER, RECIST, Aromatase Inhibitors/adverse effects

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/24135766
http://europepmc.org/abstract/MED/24135766
https://ir.ymlib.yonsei.ac.kr/handle/22282913/88927
https://www.ncbi.nlm.nih.gov/pubmed/24135766
https://pubmed.ncbi.nlm.nih.gov/24135766/
https://mdanderson.elsevierpure.com/en/publications/prolonged-clinical-benefit-from-the-maintenance-hormone-therapy-i
https://yonsei.pure.elsevier.com/en/publications/prolonged-clinical-benefit-from-the-maintenance-hormone-therapy-i

Diabète et ostéoporose

Autori: Ferrari, Serge Livio

Zdroj: Revue médicale suisse, Vol. 9, No 390 (2013) pp. 1256-1259

Predmety: ddc:616, Absorptiometry, Photon, Bone Density Conservation Agents/therapeutic use, Bone Density, Osteoporosis/diagnosis/drug therapy/etiology, Selective Estrogen Receptor Modulators/therapeutic use, Osteoporotic Fractures/etiology/prevention & control, Diabetes Mellitus, Type 2/complications/drug therapy, Humans, Hypoglycemic Agents/adverse effects/therapeutic use, 3. Good health

Popis súboru: application/pdf

Prístupová URL adresa: https://archive-ouverte.unige.ch/unige:33642

Chemoprevention for breast cancer

Autori: Bozovic, Ivana de Azambuja, Evandro McCaskill-Stevens, Worta a ďalší

Zdroj: Cancer Treatment Reviews. 38:329-339

Predmety: Selective Estrogen Receptor Modulators, Antineoplastic Agents, Hormonal, Breast Neoplasms -- drug therapy -- epidemiology -- prevention & control, Selective Estrogen Receptor Modulators -- therapeutic use, Cost-Benefit Analysis, Antineoplastic Agents, Breast Neoplasms, Tamoxifen -- therapeutic use, Chemoprevention, Risk Assessment, 03 medical and health sciences, Breast cancer, 0302 clinical medicine, Humans, Hormonal -- therapeutic use, Raloxifene -- therapeutic use, Clinical Trials as Topic, Aromatase Inhibitors, Prevention, 3. Good health, Cancérologie, Tamoxifen, Aromatase inhibitors, Raloxifene Hydrochloride, Aromatase Inhibitors -- therapeutic use, Chemoprevention -- economics, Female, Raloxifene

Popis súboru: 1 full-text file(s): application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/21856081
https://europepmc.org/article/MED/21856081
https://core.ac.uk/display/17350218
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144336/Details
https://www.sciencedirect.com/science/article/pii/S0305737211001721
https://www.ncbi.nlm.nih.gov/pubmed/21856081

EMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis

Autori: Palacios, Santiago Brincat, Mark Erel, C Tamer a ďalší

Zdroj: Maturitas. 71:194-198

Predmety: Selective Estrogen Receptor Modulators, Lasofoxifene, Selective Estrogen Receptor Modulators -- therapeutic use, Bazedoxifene, Thiophenes, Bone -- prevention & control, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal -- therapeutic use, Fractures, Bone, 03 medical and health sciences, Postmenopausal osteoporosis, 0302 clinical medicine, Monoclonal, Organometallic Compounds, Humans, Postmenopausal -- drug therapy, Humanized, Osteoporosis, Postmenopausal, Bone Density Conservation Agents -- therapeutic use, Bone Density Conservation Agents, Diphosphonates, Antibodies, Monoclonal, Thiophenes -- therapeutic use, Sciences bio-médicales et agricoles, Organometallic Compounds -- therapeutic use, 3. Good health, Tamoxifen, Diphosphonates -- therapeutic use, Osteoporosis, Female, Denosumab, Selective estrogen receptor modulators, Fractures, Raloxifene

Popis súboru: 1 full-text file(s): application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/22176952
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/148095/Details
https://www.ncbi.nlm.nih.gov/pubmed/22176952
https://pubmed.ncbi.nlm.nih.gov/22176952/
http://core.ac.uk/display/16492206
https://www.sciencedirect.com/science/article/pii/S0378512211003951
https://avesis.istanbul.edu.tr/yayin/f29fa430-2860-46a7-b3f7-9f307d41603d/emas-clinical-guide-selective-estrogen-receptor-modulators-for-postmenopausal-osteoporosis
https://pergamos.lib.uoa.gr/uoa/dl/object/3090213

Expression of estrogen receptors in the pelvic floor of pre- and post-menopausal women presenting pelvic organ prolapse

Autori: Marcus-Braun, Naama Eboue, Cyril Abeguile, Genevieve a ďalší

Zdroj: Folia Histochemica et Cytobiologica. 49(3):521-527

Predmety: Adult, Selective estrogen receptor modulators - metabolism, Biopsy, Postmenopause - metabolism, Pelvic organ prolapse - metabolism, Pelvic floor - pathology, Pelvic floor - surgery, Pelvic organ prolapse - surgery, Pelvic organ prolapse - drug therapy, Selective estrogen receptor modulators - therapeutic use, Estrogen receptor alpha - genetics, Humans, Premenopause - metabolism, Female, Estrogen receptor alpha - metabolism, Estrogen receptor beta - metabolism, Middle aged, Estrogen receptor beta - genetics, Aged, Pelvic floor - physiology

Reproduction after breast cancer

Autori: Zervoudis, S. Iatrakis, G. Navrozoglou, I.

Zdroj: Best Practice & Research Clinical Obstetrics & Gynaecology. 24:81-86

Predmety: Selective Estrogen Receptor Modulators, Infertility, Female/chemically induced/drug therapy, Romania/epidemiology, Breast Neoplasms, Fertilization in Vitro, Reproduction/*drug effects, Primary Ovarian Insufficiency, Global Health, Embryo Transfer, Gonadotropin-Releasing Hormone, 03 medical and health sciences, 0302 clinical medicine, Fertility Agents, Female/therapeutic use, Ovulation Induction, Pregnancy, Selective Estrogen Receptor Modulators/therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Humans, Cryopreservation/methods, Gonadotropin-Releasing Hormone/agonists, Cryopreservation, Romania, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Incidence, Reproduction, Ovary, Breast Neoplasms/complications/diagnosis/epidemiology/*therapy, Fertility Agents, Female, 3. Good health, Tamoxifen/therapeutic use, Ovary/transplantation, World Health, Primary Ovarian Insufficiency/chemically induced/complications/*drug therapy, Drug Therapy, Combination, Female, Infertility, Female

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/20170848
https://www.researchreproduction.gr/educational_stuff/SEMESTER_B/KYISI%20YPSILOU%20KINDYNOY/Reproduction%20after%20breast%20cancer.pdf
http://www.sciencedirect.com/science/article/pii/S1521693409001114
https://pubmed.ncbi.nlm.nih.gov/20170848/
https://www.ncbi.nlm.nih.gov/pubmed/20170848
https://europepmc.org/abstract/MED/20170848
https://www.sciencedirect.com/science/article/pii/S1521693409001114
http://olympias.lib.uoi.gr/jspui/handle/123456789/18642

Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis

Autori: Xu, L Kung, AWC Chu, EYW

Zdroj: Expert Opinion on Pharmacotherapy. 10:1377-1385

Predmety: Selective Estrogen Receptor Modulators, 0301 basic medicine, Selective Estrogen Receptor Modulators - therapeutic use, Clinical Trials as Topic, 0303 health sciences, Osteoporosis, Postmenopausal - drug therapy, Indoles, 3. Good health, 03 medical and health sciences, Indoles - therapeutic use, Osteoporosis, Humans, Postmenopausal - drug therapy, Osteoporosis, Postmenopausal

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/19445558
https://hub.hku.hk/handle/10722/59182
https://core.ac.uk/display/37894888
https://europepmc.org/article/MED/19445558
https://www.tandfonline.com/doi/full/10.1517/14656560902980228
https://www.ncbi.nlm.nih.gov/pubmed/19445558
http://hdl.handle.net/10722/59182

Potential Role of UGT Pharmacogenetics in Cancer Treatment and Prevention: Focus on Tamoxifen

Autori: Lazarus, Philip Blevins-Primeau, Andrea S Zheng, Yan a ďalší

Zdroj: Annals of the New York Academy of Sciences. 1155:99-111

Predmety: Selective Estrogen Receptor Modulators, Selective Estrogen Receptor Modulators - therapeutic use, Antineoplastic Agents, Hormonal, Breast Neoplasms - drug therapy, Antineoplastic Agents, Breast Neoplasms, Cell Line, 03 medical and health sciences, Breast Neoplasms - prevention & control, 0302 clinical medicine, Cell Line, Tumor, Hormonal - pharmacology, Humans, Glucuronosyltransferase - metabolism, Glucuronosyltransferase, Breast Neoplasms - enzymology, Selective Estrogen Receptor Modulators - pharmacology, Tumor, Breast Neoplasms - genetics, Tamoxifen - therapeutic use, 3. Good health, Tamoxifen, Tamoxifen - pharmacology, Pharmacogenetics, Female, Glucuronosyltransferase - genetics, Hormonal - therapeutic use

Prístupová URL adresa: https://europepmc.org/articles/pmc2694135?pdf=render
https://pubmed.ncbi.nlm.nih.gov/19250197
http://ui.adsabs.harvard.edu/abs/2009NYASA1155...99L/abstract
https://ascpt.onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2009.04114.x
https://www.ncbi.nlm.nih.gov/pubmed/19250197
http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2009.04114.x/full
https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1111/j.1749-6632.2009.04114.x
https://pennstate.pure.elsevier.com/en/publications/potential-role-of-ugt-pharmacogenetics-in-cancer-treatment-and-pr

Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture

Autori: Rabenda, Véronique Vanoverloop, Johan Fabri, Valerie a ďalší

Zdroj: The journal of bone and joint surgery : American volume

Predmety: Selective Estrogen Receptor Modulators, Bone Density Conservation Agents/therapeutic use, Databases, Factual, Osteoporosis, Postmenopausal/complications/prevention & control, Sciences de la santé humaine, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Belgium, Selective Estrogen Receptor Modulators/therapeutic use, Patient Compliance/statistics & numerical data, Humans, Hip Fractures/epidemiology/therapy, Human health sciences, Practice Patterns, Physicians', Belgium/epidemiology, Osteoporosis, Postmenopausal, Hospitalization/statistics & numerical data, Aged, Retrospective Studies, Alendronate, Bone Density Conservation Agents, Diphosphonates, Hip Fractures, Physician's Practice Patterns/statistics & numerical data, Alendronate/therapeutic use, Middle Aged, 3. Good health, Hospitalization, Patient Compliance, Female, Human medicine, Diphosphonates/therapeutic use, General & internal medicine, Médecine générale & interne

Prístupová URL adresa: https://orbi.uliege.be/bitstream/2268/20332/1/Low%20incidence%20of%20anti%20osteoporosis%20treatment%20after%20hip%20fracture.pdf
https://pubmed.ncbi.nlm.nih.gov/18829912
https://orbi.uliege.be/handle/2268/20332
http://orbi.ulg.ac.be/handle/2268/20332
https://pubmed.ncbi.nlm.nih.gov/18829912/
https://hdl.handle.net/10067/934770151162165141

Poor Outcome of Hormone Receptor–Positive Breast Cancer at Very Young Age Is Due to Tamoxifen Resistance: Nationwide Survival Data in Korea—A Report From the Korean Breast Cancer Society

Autori: Seung-Sang Ko Joon Jeong Wonshik Han a ďalší

Prispievatelia: Seung-Sang Ko Joon Jeong Wonshik Han a ďalší

Zdroj: Journal of Clinical Oncology. 25:2360-2368

Predmety: Adult, Selective Estrogen Receptor Modulators, Drug Resistance, Breast Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Breast Neoplasms/drug therapy, Selective Estrogen Receptor Modulators/therapeutic use, Receptors, Antineoplastic Combined Chemotherapy Protocols, Humans, Progesterone/metabolism, Registries, Korea, Tamoxifen/therapeutic use, Age Factors, Middle Aged, Neoplasm, Prognosis, 3. Good health, Tamoxifen, Receptors, Estrogen, Breast Neoplasms/metabolism, Drug Resistance, Neoplasm, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Female, Breast Neoplasms/mortality, Estrogen/metabolism, Receptors, Progesterone

Popis súboru: 2360~2368

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/17515570
https://pubmed.ncbi.nlm.nih.gov/17515570/
https://s-space.snu.ac.kr/handle/10371/11610
https://www.jco.ascopubs.org/content/25/17/2360.full
https://www.ncbi.nlm.nih.gov/pubmed/17515570
https://yonsei.pure.elsevier.com/en/publications/poor-outcome-of-hormone-receptor-positive-breast-cancer-at-very-y
https://snucm.elsevierpure.com/en/publications/poor-outcome-of-hormone-receptor-positive-breast-cancer-at-very-y

Tamoxifen: Important considerations of a multi-functional compound with organ-specific properties

Autori: Singh, Maneesh N. Stringfellow, Helen F. Paraskevaidis, Evangelos a ďalší

Zdroj: Cancer Treatment Reviews. 33:91-100

Predmety: Selective Estrogen Receptor Modulators, 0301 basic medicine, Breast Neoplasms/*drug therapy, Breast Neoplasms, 3. Good health, Tamoxifen, 03 medical and health sciences, 0302 clinical medicine, Organ Specificity, Tamoxifen/*therapeutic use, Selective Estrogen Receptor Modulators/*therapeutic use, Humans, Female

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/17178195
https://pubmed.ncbi.nlm.nih.gov/17178195/
https://europepmc.org/article/MED/17178195
http://www.sciencedirect.com/science/article/pii/S030573720600185X
https://www.sciencedirect.com/science/article/abs/pii/S030573720600185X
https://eprints.lancs.ac.uk/id/eprint/31377
http://olympias.lib.uoi.gr/jspui/handle/123456789/24724

The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response

Autori: Loi, Sherene Piccart-Gebhart, Martine Sotiriou, Christos

Zdroj: Critical Reviews in Oncology/Hematology. 61:187-194

Predmety: Selective Estrogen Receptor Modulators, Estrogen -- metabolism, Estrogen -- classification, Selective Estrogen Receptor Modulators -- therapeutic use, Drug Resistance, Breast Neoplasms -- drug therapy, Breast Neoplasms, Tamoxifen -- therapeutic use, Estrogen -- genetics, 03 medical and health sciences, 0302 clinical medicine, Receptors, Humans, Cell Proliferation, Gene Expression Profiling, Cell Cycle, Breast Neoplasms -- genetics, Sciences bio-médicales et agricoles, Prognosis, 3. Good health, Tamoxifen, Receptors, Estrogen, Drug Resistance, Neoplasm, Biological Markers, Female, Neoplasm -- genetics, Biomarkers

Popis súboru: 1 full-text file(s): application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/17088071
https://findanexpert.unimelb.edu.au/scholarlywork/1247849-the-use-of-gene-expression-profiling-to-better-understand-the-clinical-heterogeneity-of-estrogen-receptor-positive-breast-cancers-and-tamoxifen-response
https://www.sciencedirect.com/science/article/pii/S1040842806002010
https://core.ac.uk/display/8854312
https://www.ncbi.nlm.nih.gov/pubmed/17088071
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/54559/Details
https://pubmed.ncbi.nlm.nih.gov/17088071/

Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial

Autori: Ingle, James N Tu, Dongsheng Pater, Joseph L a ďalší

Zdroj: Breast Cancer Research and Treatment. 99:295-300

Predmety: Selective Estrogen Receptor Modulators, 0301 basic medicine, Time Factors, Selective Estrogen Receptor Modulators -- therapeutic use, Breast Neoplasms -- drug therapy, Antineoplastic Agents, Breast Neoplasms, Tamoxifen -- therapeutic use, Disease-Free Survival, Drug Administration Schedule, 03 medical and health sciences, Antineoplastic Agents -- administration & dosage, 0302 clinical medicine, Double-Blind Method, Aromatase Inhibitors -- administration & dosage, Receptors, Nitriles, Progesterone -- analysis, Chemotherapy, Humans, Triazoles -- administration & dosage, Adjuvant, Aged, Proportional Hazards Models, Adjuvant hormonal therapy, Aromatase Inhibitors, Early breast cancer, Nitriles -- therapeutic use, Sciences bio-médicales et agricoles, Middle Aged, Breast Neoplasms -- mortality, Survival Analysis, Breast Neoplasms -- chemistry, 3. Good health, Postmenopause, Tamoxifen, Nitriles -- administration & dosage, Treatment Outcome, Receptors, Estrogen, Chemotherapy, Adjuvant, Estrogen -- analysis, Letrozole, Antineoplastic Agents -- therapeutic use, Breast Neoplasms -- pathology, Aromatase Inhibitors -- therapeutic use, Triazoles -- therapeutic use, Female, Receptors, Progesterone

Popis súboru: No full-text files

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/16541302
https://www.research.ed.ac.uk/en/publications/duration-of-letrozole-treatment-and-outcomes-in-the-placebo-contr
http://www.ncbi.nlm.nih.gov/pubmed/16541302
https://mayoclinic.pure.elsevier.com/en/publications/duration-of-letrozole-treatment-and-outcomes-in-the-placebo-contr
https://link.springer.com/article/10.1007/s10549-006-9207-y
https://jhu.pure.elsevier.com/en/publications/duration-of-letrozole-treatment-and-outcomes-in-the-placebo-contr-3
https://www.research.ed.ac.uk/portal/en/publications/duration-of-letrozole-treatment-and-outcomes-in-the-placebocontrolled-ncic-ctg-ma17-extended-adjuvant-therapy-trial(50e0543e-f71f-447e-a450-a14d8df52d45).html

Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea

Autori: Świątecka, Jolanta Oczeretko, Edward Laudański, Piotr a ďalší

Zdroj: Gynecological Endocrinology. 22(12):698-703

Predmety: Tamoksyfen - stosowanie lecznicze, Wynik leczenia, Skurcz macicy - wpływ środków chemicznych, Tamoxifen - administration & dosage, Monitorowanie czynności skurczowej macicy - metody, Dysmenorrhea - drug therapy, Tamoxifen - therapeutic use, Selective estrogen receptor modulators - administration & dosage, Skurcz macicy - fizjologia, Uterine monitoring - methods, Selektywne modulatory receptora estrogenowego - dawkowanie, Selective estrogen receptor modulators - therapeutic use, Uterine contraction - drug effects, Selektywne modulatory receptora estrogenowego - stosowanie lecznicze, Uterine contraction - physiology, Treatment outcome, Miesiączkowanie bolesne - farmakoterapia, Tamoksyfen - dawkowanie

Selektywne modulatory receptora estrogenowego (SERM) w leczeniu i profilaktyce schorzeń wieku postmenopauzalnego

Zdroj: Lek w Polsce. 13(12):75-80

Predmety: Postmenopause, Tamoksyfen - stosowanie lecznicze, Selective estrogen receptor modulators - therapeutic use, Selektywne modulatory receptora estrogenowego - stosowanie lecznicze, Okres pomenopauzalny, Raloxifene - therapeutic use, Raloksyfen - stosowanie lecznicze, Tamoxifen - therapeutic use

Combined Treatment With Buserelin and Tamoxifen in Premenopausal Metastatic Breast Cancer: a Randomized Study

Autori: Klijn, J G Beex, Louk Mauriac, L a ďalší

Zdroj: Journal of the National Cancer Institute, 92, 11, pp. 903-911

Predmety: Adult, Selective Estrogen Receptor Modulators, Time Factors, Antineoplastic Agents, Hormonal, Selective Estrogen Receptor Modulators -- therapeutic use, Breast Neoplasms -- drug therapy, Antineoplastic Agents, Breast Neoplasms, Tamoxifen -- therapeutic use, Buserelin, Disease-Free Survival, Gonadotropin-Releasing Hormone, Experimental diagnostics and therapy of malignancies, Drug Therapy, SDG 3 - Good Health and Well-being, Estrogen Receptor Modulators, Risk Factors, Menstrual Cycle -- drug effects, Humans, Hormonal -- therapeutic use, Breast Neoplasms -- blood, Prospective Studies, Gonadotropin-Releasing Hormone -- blood, Menstrual Cycle, Estradiol, Estrogen Receptor Modulators -- therapeutic use, Sciences bio-médicales et agricoles, Middle Aged, Prognosis, Survival Analysis, 3. Good health, Buserelin -- therapeutic use, Tamoxifen, Treatment Outcome, Premenopause, Combination, Drug Therapy, Combination, Female, EMC MM-03-86-01, Estradiol -- blood

Popis súboru: No full-text files

Prístupová URL adresa: https://academic.oup.com/jnci/article-pdf/92/11/903/10891912/903.pdf
https://pubmed.ncbi.nlm.nih.gov/10841825
https://pure.eur.nl/en/publications/bd315119-1b11-4919-aae8-e784fa14fa6e
https://core.ac.uk/display/18522926
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55331/Details
https://repub.eur.nl/pub/9380/
https://academic.oup.com/jnci/article/92/11/903/2905841
https://europepmc.org/article/MED/10841825
https://repub.eur.nl/pub/9380/10841825.pdf
http://hdl.handle.net/2066/124517

La chimio-prevention du cancer du sein: un espoir justifie? [Chemoprevention of breast cancer: a hope justified?]

Autori: Buser, K. Delaloye, J. F.

Predmety: Adult Aged Antineoplastic Agents, Hormonal/*therapeutic use Australia Breast Neoplasms/*prevention & control Chemoprevention Europe Female Humans Middle Aged Randomized Controlled Trials Selective Estrogen Receptor Modulators/*therapeutic use Tamoxifen/*therapeutic use United States

Relation: Revue Médicale de la Suisse Romande; https://iris.unil.ch/handle/iris/48707; serval:BIB_4A6DD8E8B246

Dostupnosť: https://iris.unil.ch/handle/iris/48707

Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer / Adjuverende antihormonal behandling af kvinder med primaer operabel brystkraeft

Autori: Tuxen, M K Nielsen, D L Lindberg, H a ďalší

Zdroj: Ugeskrift for Laeger. 169(4):297